American Pharmacogenomics Association
|

FOR IMMEDIATE RELEASE – American Pharmacogenomics Association Issues Statement on Final FDA Rule for Laboratory Developed Tests (LDTs)

The American Pharmacogenomics Association (APGxA) today issued a statement on the Food and Drug Administration’s (FDA) final rule regarding the regulation of laboratory-developed tests (LDTs).

End of content

End of content